Connect with us

Technology

Netech Corporation Releases New State-of-the-Art EEG Simulator: MiniSim EEG 2000

Published

4 months ago

on

Netech Corporation unveils the MiniSim EEG 2000, a cutting-edge, stand-alone EEG simulator, featuring 16 independent signal outputs and a compact, user-friendly design

FARMINGDALE, N.Y., Sept. 5, 2024 /PRNewswire-PRWeb/ — Netech Corporation, a leading innovator and manufacturer of biomedical test instruments, is proud to introduce its newest product, a stand-alone electroencephalogram (EEG) simulator: MiniSim EEG 2000. The hand-held patient simulator is uniquely designed to accurately simulate six different kinds of EEG waveforms: alpha, theta, gamma, delta, and beta brain waves, along with auditory brain response (ABR) waves. MiniSim EEG 2000 is the latest version of one of the company’s best-selling devices, the MiniSim EEG.

We have been serving the biomedical community worldwide since 1987, and we are excited to add MiniSim EEG 2000 to our growing line of patient simulators.

The release of the new EEG simulator is an important development for Netech Corporation as well as the biomedical equipment manufacturers, medical equipment service companies, and the healthcare industry. Here’s why: EEG monitoring devices are essential tools for testing brain activity and identifying brain-related disorders, such as tumors, injuries, stroke, and epilepsy. Ensuring the performance of these monitoring instruments is crucial, which is where MiniSim EEG 2000 excels.

With 16 independent signal outputs, MiniSim EEG 2000 makes it easy for healthcare professionals to confirm the precision of various EEG monitoring devices, including recorders, sleep study monitors, and multi-channel EEG monitoring systems. This, in turn, facilitates the accurate monitoring, diagnosis, and treatment of patients.

“We have been serving the biomedical community worldwide since 1987, and we are excited to add MiniSim EEG 2000 to our growing line of patient simulators,” said Dr. Mohan Das, founder and CEO of Netech Corporation. “This one-of-a-kind instrument highlights our commitment to providing the biomedical community with reliable instruments for the accurate testing and calibration of various patient care equipment.”

Netech Corporation’s revolutionary EEG simulator is also capable of measuring electrocardiogram (ECG) waveforms, along with performance waveforms, such as sine, square and triangle. The unit serves the critical function of helping ensure that the EEG machine being used for patients is in tolerance, which further enhances the value of the company’s patient simulator in the marketplace.

MiniSim EEG 2000 is one of the most advanced and versatile patient simulators on the market today. The device is distinguished by its compact, lightweight, user-friendly design and impressive functionality. MiniSim EEG 2000’s display incorporates a high-contrast 128 X 64 LCD with LED backlighting for easy viewing. Its keypad features soft-touch tactile buttons that offer dedicated key functions. It also has an interactive menu-driven interface that makes it easy for users to select from a variety of functions. In addition, the product has patented EEG cup electrodes that are simple to hook up, and it operates on a rechargeable battery, making it ideal for performance testing all EEG instrumentation.

Patient simulators—also referred to as physiological simulators or vital sign rhythm generators—are invaluable tools for biomedical personnel to accurately evaluate and verify the performance of patient monitoring systems. Essentially, a human patient simulator mimics physiological parameters, such as ECG, arrhythmia waveforms, blood pressure, respiration and temperature. Netech Corporation currently offers four different models of patient simulators, with MiniSim EEG 2000 being the latest creation in this important group of devices.

Netech Corporation has a strong reputation for creating high-quality medical equipment testing products like MiniSim EEG 2000. It is committed to manufacturing state-of-the-art products that satisfy the evolving technological needs and standards of the medical industry. All of the company’s medical testing products—which are made in the United States—are tested, calibrated according to the ISO 9001 quality management system, and comply with National Institute of Standards and Technology (NIST) guidelines. In addition, each of its products comes with a NIST certificate of calibration and is backed by a two-year warranty, excellent customer service, and outstanding technical support.

For more information about Netech Corporation and its new MiniSim EEG 2000 patient simulator, please visit www.netechbiomedical.com or contact Global Sales and Marketing Manager Steven Gonzalez at sales@netechbiomedical.com.

About Netech Corporation

Based in Farmingdale, N.Y., Netech Corporation has been designing and manufacturing innovative biomedical and industrial test equipment since 1987. Its mission is to provide the biomedical industry with the highest quality medical equipment testing instruments and knowledge that fulfill their wants and needs at the right price. As such, Netech Corporation strives to empower the biomedical industry by manufacturing easy-to-use test instruments while leading the way with innovation and ultimate customer satisfaction. The company produces a broad array of affordable biomedical test instruments, including digital pressure/vacuum meters and gauges, patient simulators, electrical safety analyzers, defibrillator analyzers, cardiac output simulators, and EEG simulators.

Media Contact

Steven Gonzalez, Global Sales and Marketing Manager, Netech Corporation, 1 (631) 531-0100 1015, s.gonzalez@netechbiomedical.com, https://www.netechbiomedical.com

View original content to download multimedia:https://www.prweb.com/releases/netech-corporation-releases-new-state-of-the-art-eeg-simulator-minisim-eeg-2000-302239662.html

SOURCE Netech Corporation

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

For Fourth Year, Everspring Recognized Among Chicago’s Best Places to Work

Published

55 minutes ago

on

January 8, 2025

By

Award Recognition Reflects Company’s Continued Momentum, Growth and Innovation in Higher Ed Technology

CHICAGO, Jan. 8, 2025 /PRNewswire/ — Everspring, a rapidly growing force in education technology, today announced its recognition on Built In’s 2025 Best Places to Work Awards, earning a coveted spot on Chicago’s 100 Best Midsize Companies list. This achievement comes at a pivotal moment for Everspring, following the successful launch of its VIA enrollment marketing platform and continued strategic partnerships that enable universities to adapt and thrive in a dynamic higher ed landscape.

“This recognition reflects the extraordinary momentum we’re experiencing at Everspring,” says Beth Hollenberg, CEO of Everspring. “Our team’s innovative spirit and dedication to transforming higher education have created an environment where top talent thrives. As we continue to expand our technology solutions and deepen our university partnerships, this award validates our commitment to fostering a workplace that attracts and retains the industry’s brightest minds.”

The honor arrives as Everspring expands its comprehensive education services with powerful SaaS technology offerings. The company’s recent launch of VIA, its enrollment marketing intelligence platform, exemplifies how Everspring’s growing suite of solutions addresses critical challenges in higher education, from disconnected data to enrollment optimization.

“Being recognized as a Best Place to Work is a testament to these companies’ commitment to building a workplace where individuals and innovation thrive,” says Built In CEO and Founder, Maria Christopoulos Katris. “At Built In, we understand that great companies are powered by great teams, and this achievement showcases their dedication to fostering a culture of growth, inclusivity, and excellence. Congratulations on this well-deserved honor.”

Built In determines the winners of Best Places to Work using company data about compensation and benefits, weighing criteria such as remote and flexible work opportunities, DEI programs, and other people-first cultural offerings that today’s tech professionals value most.

About Built In
Built In is the “always on” recruiting platform that reaches the tech professionals that other leading recruiting platforms don’t. Designed to help companies hire expert tech talent, Built In continuously drives brand awareness with content. Monthly, millions of the industry’s most in-demand global tech professionals visit our site to stay ahead of tech trends and news, learn skills to accelerate their careers, find the right job opportunities and get hired. Thousands of companies, from fast-growing startups to the largest enterprises rely on Built In. www.builtin.com

About Built In’s Best Places to Work
Built In’s annual Best Places to Work program honors companies with the best total rewards packages across the U.S. and in the following tech hubs: Atlanta, Austin, Boston, Chicago, Colorado, Dallas, Houston, Los Angeles, Miami, New York, San Diego, San Francisco, Seattle and Washington DC. Best Places to Work is distinct because its algorithm selects tech companies that build their offerings specifically around what tech professionals value in a workplace. https://employers.builtin.com/best-places-to-work

About Everspring
Everspring is a leading provider of education technology and services solutions for higher education. Our advanced technology, proven marketing approach, and robust faculty support and instructional design services deliver outstanding outcomes for our university partners, powering their success online. Everspring offers a range of full-service turnkey solutions, as well as standalone fee-for-service offerings, and innovative self-service products that enable universities to establish themselves as leaders in the digital delivery of higher education. Based in Chicago, Everspring serves a growing number of colleges and universities nationwide.

Visit www.everspringpartners.com for more information.

View original content to download multimedia:https://www.prnewswire.com/news-releases/for-fourth-year-everspring-recognized-among-chicagos-best-places-to-work-302345978.html

SOURCE Everspring

Continue Reading

Technology

HCMF Group Unveils Cutting-Edge Smart Cockpit and Body Mechatronic Systems at CES 2025

Published

55 minutes ago

on

January 8, 2025

By

LAS VEGAS, Jan. 8, 2025 /PRNewswire/ — HCMF Group, a global leader in Tier 1 automotive parts and systems, is proud to unveil its groundbreaking advancements in smart cockpit and body mechatronic systems at CES 2025, held from January 7 to January 9. Partnering with industry leaders such as AUO, AGC, Inventec, TMYTEK (TMY Technology Inc.), BenQ Materials, and KINPO GROUP, HCMF is redefining intelligent mobility through transformative innovations and unmatched integration capabilities.

HCMF’s showcase features its integrated vehicle control system, developed with Inventec, which centralizes functionalities onto the front dashboard. This system combines an intuitive user interface, a UWB electronic key, and wireless charging, offering a seamless and futuristic cockpit experience. Also debuting is HCMF’s Micro LED transparent smart window technology, created with AUO and AGC. These high-transparency touch displays are integrated into rear car windows with patented window regulator mechanism, enabling applications such as real-time driving information, AR gaming, personal calendars, and rear-view mirror functions for enhanced convenience and safety.

HCMF’s smart glass solutions, developed with BenQ Materials, deliver privacy and energy efficiency through advanced PDLC 98 black dimming film. These materials block heat and UV rays while providing futuristic aesthetics. Passenger safety takes center stage with the second-generation Child Presence Detection (CPD) system, introduced with TMYTEK. Capable of detecting subtle life signs such as heartbeats and breathing, this system sends real-time alerts to the user’s smartphone, preventing safety risks for children or pets left inside the vehicle.

For rear-seat entertainment, HCMF introduces its foldable 28.6-inch, 32:9 ceiling display featuring JET OPTO’s dual-view single-screen technology. Passengers can view separate content or participate in virtual meetings, redefining in-car leisure and productivity. The company also showcases systems tailored for electric vehicles, such as a front hood automatic opening system and a centralized door control system (DCU) that combines E-latch, radar-based collision avoidance, and automatic opening mechanisms. Additionally, the innovative automatic tailgate system, developed with KINPO GROUP, delivers a user-friendly experience by overcoming traditional design limitations.

Jeffrey Hsi, Chief Innovation Officer of HCMF Group, remarked, “CES 2025 is a pivotal platform for HCMF to showcase its leadership in smart cockpit and body mechatronic systems. We are committed to driving innovation and breakthroughs, advancing automotive technology to deliver safer, more convenient, and enjoyable smart mobility experiences for consumers worldwide.”

HCMF’s participation at CES 2025 underscores its leadership in smart cockpit technologies and collaborative innovation with global partners. From enhancing passenger safety to redefining in-car entertainment and advancing intelligent mobility, HCMF is setting new benchmarks in automotive intelligence and automation. The company remains focused on innovation-driven research and development, delivering future-ready solutions that create value for the global automotive industry and its consumers.

About HCMF Group

HCMF was established in 1961 and as a global automobile Tier 1 system supplier with more than 60 years experience in design and manufacturing. HCMF has around 40 sites globally to provide tailored service to our customers. Our vast knowledge and expertise through years of product experience provide solutions to satisfy our customer needs. We believe strongly in upholding integrity and cooperation to maximize benefits to our customers and partners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hcmf-group-unveils-cutting-edge-smart-cockpit-and-body-mechatronic-systems-at-ces-2025-302345908.html

SOURCE HCMF Group

Continue Reading

Technology

DELFI Diagnostics to Participate in J.P. Morgan Healthcare Conference

Published

55 minutes ago

on

January 8, 2025

By

Leader in liquid biopsy, cancer screening, and monitoring speaks at largest healthcare investment symposium

BALTIMORE and PALO ALTO, Calif., Jan. 8, 2025 /PRNewswire/ —  DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, today announced the company will participate in the upcoming 43rd Annual J.P. Morgan Healthcare Conference in San Francisco.

The company’s management is scheduled to present and participate in a Q&A session on Thursday, January 16, 2025, at 7:30 a.m. PT/10:30 a.m. ET. To learn more about DELFI Diagnostics, visit DELFIDiagnostics.com

About DELFI Diagnostics
DELFI Diagnostics is developing next-generation, blood-based tests that are accurate, accessible, and deliver a new way to help detect cancer. DELFI tests are built to solve the highest-burden population health issues, including in historically underserved demographics, and have the potential to save lives on a global scale. FirstLook Lung, for individuals eligible for lung cancer screening, is our first laboratory-developed screening test and requires a simple blood draw that can be incorporated with routine blood work. The test is based on fragmentomics, the discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments in the blood. The DELFI platform applies advanced machine-learning technology to whole-genome sequencing data to assess individuals’ cfDNA fragments against populations with and without cancer. FirstLook Lung uses these millions of data points to reliably identify individuals who may have cancer detected through low-dose CT, including early-stage disease, with a negative predictive value of 99.8 percent. This test has not been cleared or approved by the FDA.

View original content to download multimedia:https://www.prnewswire.com/news-releases/delfi-diagnostics-to-participate-in-jp-morgan-healthcare-conference-302344795.html

SOURCE DELFI Diagnostics

Continue Reading

Trending